FDA Approves CHILDRENS ADVIL — Haleon US Holdings LLC

# FDA Approves Children's Advil (Ibuprofen) for Haleon US Holdings LLC The FDA approval of Children's Advil marks Haleon US Holdings LLC's entry into the pediatric pain relief market, positioning the company to capture significant share in the over-the-counter children's analgesic segment, which has historically been dominated by acetaminophen-based products. This oral ibuprofen formulation expands Haleon's consumer healthcare portfolio and opens new revenue streams in the lucrative pediatric care category, where parents increasingly seek alternatives to single-ingredient fever and pain treatments